ArticleRSC medicinal chemistry2022

Inhibition of MARK4 by serotonin as an attractive therapeutic approach to combat Alzheimer's disease and neuroinflammation.

Anas Shamsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.